Hematopoietic Stem Cell Mobilization
"Hematopoietic Stem Cell Mobilization" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The release of stem cells from the bone marrow into the peripheral blood circulation for the purpose of leukapheresis, prior to stem cell transplantation. Hematopoietic growth factors or chemotherapeutic agents often are used to stimulate the mobilization.
| Descriptor ID |
D019650
|
| MeSH Number(s) |
E02.095.410
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hematopoietic Stem Cell Mobilization".
Below are MeSH descriptors whose meaning is more specific than "Hematopoietic Stem Cell Mobilization".
This graph shows the total number of publications written about "Hematopoietic Stem Cell Mobilization" by people in this website by year, and whether "Hematopoietic Stem Cell Mobilization" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 2 | 2 |
| 2000 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hematopoietic Stem Cell Mobilization" by people in Profiles.
-
Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica. Neurology. 2019 10 29; 93(18):e1732-e1741.
-
Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis. Biol Blood Marrow Transplant. 2015 Jan; 21(1):165-71.
-
Adult stem cell mobilization enhances intramembranous bone regeneration: a pilot study. Clin Orthop Relat Res. 2012 Sep; 470(9):2503-12.
-
Cellular therapies supplement: strategies for improving transplant efficiency in the context of cellular therapeutics. Transfusion. 2011 Nov; 51 Suppl 4:125S-137S.
-
Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myeloma. Clin Lymphoma Myeloma. 2006 Nov; 7(3):210-6.
-
Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells. Adult AIDS Clinical Trials Group 285 Study Team. Blood. 2000 Jan 01; 95(1):48-55.
-
Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood. 1998 Nov 15; 92(10):3505-14.
-
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies. Bone Marrow Transplant. 1998 Nov; 22(10):947-55.